NSF/ANSI 455-4:2022
Superseded
View Superseded by
Good Manufacturing Practices for Over-the-Counter Drugs
English, Chinese
04-01-2023
12-09-2024
This standard is intended to define a standardized approach for auditing to determine the level of compliance of OTC drug products to 21 C.F.R. Part 210 Current Good Manufacturing Practice in Manufacturing, Processing, Packing, or Holding of Drugs; General and 21 C.F.R. Part 211 Current Good Manufacturing Practice for Finished Pharmaceuticals, International Council for Harmonisation of Technical Requirements for Pharmaceutical for Human Use (ICH) Quality Guidelines, 1, 7 and 10, as well as incorporating additional retailer requirements.
| DocumentType |
Standard
|
| Pages |
64
|
| PublisherName |
NSF International
|
| Status |
Superseded
|
| SupersededBy | |
| Supersedes |
| ISO/IEC 17065:2012 | Conformity assessment — Requirements for bodies certifying products, processes and services |
Please Login or Create an Account so you can add users to your Multi user PDF Later.
Important note : All end users must be registered with an Account prior to user licenses being assigned.
Users cannot be edited or removed once added to your Multi user PDF.